# TG Therapeutics, Inc.: filings

TGTX · Nasdaq · CIK 1001316 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tgtx.md) · [Financials](/companies/tgtx/financials.md) · [Filings](/companies/tgtx/filings.md) · [Insiders](/companies/tgtx/insiders.md)

## Reports and events: 312 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 197, 4 170, 10-Q 53, SC 13G/A 40, 10-K 18, 144 18, DEF 14A 17, SC 13G 16, 424B5 15, 3 14, UPLOAD 13, 424B3 11, CORRESP 11, CT ORDER 9, EFFECT 9, DEFA14A 8, PRE 14A 8, SC 13D/A 8, 8-K/A 7, S-3 5, S-8 5, PX14A6G 4, 10-K/A 3, 10-Q/A 3, 5 3, POS AM 3, S-1 3, S-3ASR 3, SCHEDULE 13G/A 3, 8-A12B 2, ARS 2, D 2, D/A 2, REGDEX/A 2, RW 2, SC 13D 2, 144/A 1, 424B1 1, 4/A 1, CERTNAS 1, NT 10-Q 1, PRER14A 1, S-1/A 1, S-3/A 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-05 | 17:01 ET | [10-Q](/filings/0001437749-26-025955.md) | Quarterly report, period 2026-06-30 | 0001437749-26-025955 |
| 2026-08-03 | 07:05 ET | [8-K](/filings/0001437749-26-025304.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-025304 |
| 2026-06-12 | 16:32 ET | [8-K](/filings/0001437749-26-020491.md) | 5.07 Shareholder vote results | 0001437749-26-020491 |
| 2026-06-03 | 07:34 ET | [8-K](/filings/0001437749-26-019262.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-019262 |
| 2026-05-27 | 16:34 ET | [8-K](/filings/0001437749-26-018586.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-018586 |
| 2026-05-06 | 17:00 ET | [10-Q](/filings/0001437749-26-015246.md) | Quarterly report, period 2026-03-31 | 0001437749-26-015246 |
| 2026-05-06 | 07:25 ET | [8-K](/filings/0001437749-26-015013.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-015013 |
| 2026-04-30 | 16:31 ET | [DEF 14A](/filings/0001437749-26-014233.md) | Proxy statement, period 2026-06-11 | 0001437749-26-014233 |
| 2026-03-20 | 16:33 ET | [8-K](/filings/0001437749-26-009253.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001437749-26-009253 |
| 2026-02-27 | 17:05 ET | [10-K](/filings/0001437749-26-006133.md) | Annual report, period 2025-12-31 | 0001437749-26-006133 |
| 2026-02-26 | 07:08 ET | [8-K](/filings/0001437749-26-005733.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-005733 |
| 2026-01-13 | 16:27 ET | [8-K](/filings/0001437749-26-001194.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-001194 |
| 2025-11-05 | 16:31 ET | [10-Q](/filings/0001437749-25-033363.md) | Quarterly report, period 2025-09-30 | 0001437749-25-033363 |
| 2025-11-03 | 07:34 ET | [8-K](/filings/0001437749-25-032658.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-032658 |
| 2025-08-08 | 16:38 ET | [10-Q](/filings/0001437749-25-025745.md) | Quarterly report, period 2025-06-30 | 0001437749-25-025745 |
| 2025-08-04 | 07:35 ET | [8-K](/filings/0001437749-25-024480.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-024480 |
| 2025-06-13 | 16:53 ET | [8-K](/filings/0001437749-25-020335.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-25-020335 |
| 2025-05-09 | 16:31 ET | [10-Q](/filings/0001437749-25-015804.md) | Quarterly report, period 2025-03-31 | 0001437749-25-015804 |
| 2025-05-05 | 07:31 ET | [8-K](/filings/0001437749-25-014402.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-014402 |
| 2025-04-30 | 16:18 ET | [DEF 14A](/filings/0001437749-25-013860.md) | Proxy statement, period 2025-06-12 | 0001437749-25-013860 |
| 2025-03-03 | 16:02 ET | [10-K](/filings/0001437749-25-005908.md) | Annual report, period 2024-12-31 | 0001437749-25-005908 |
| 2025-03-03 | 07:19 ET | [8-K](/filings/0001437749-25-005802.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-005802 |
| 2025-01-14 | 16:02 ET | [8-K](/filings/0001437749-25-001106.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-001106 |
| 2024-11-07 | 16:33 ET | [10-Q](/filings/0001437749-24-033948.md) | Quarterly report, period 2024-09-30 | 0001437749-24-033948 |
| 2024-11-04 | 07:19 ET | [8-K](/filings/0001437749-24-033055.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-033055 |
| 2024-08-09 | 16:03 ET | [10-Q](/filings/0001437749-24-025853.md) | Quarterly report, period 2024-06-30 | 0001437749-24-025853 |
| 2024-08-09 | 16:01 ET | [10-K/A](/filings/0001437749-24-025850.md) | Annual report, amended, period 2023-12-31 | 0001437749-24-025850 |
| 2024-08-06 | 07:08 ET | [8-K](/filings/0001437749-24-024718.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-024718 |
| 2024-06-17 | 16:48 ET | [8-K](/filings/0001437749-24-020510.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-24-020510 |
| 2024-05-06 | 16:59 ET | [10-Q](/filings/0001437749-24-014849.md) | Quarterly report, period 2024-03-31 | 0001437749-24-014849 |
| 2024-05-01 | 07:05 ET | [8-K](/filings/0001437749-24-014062.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-014062 |
| 2024-04-29 | 16:32 ET | [DEF 14A](/filings/0001437749-24-013719.md) | Proxy statement, period 2024-06-14 | 0001437749-24-013719 |
| 2024-02-29 | 17:23 ET | [10-K](/filings/0001437749-24-006144.md) | Annual report, period 2023-12-31 | 0001437749-24-006144 |
| 2024-02-28 | 07:24 ET | [8-K](/filings/0001437749-24-005802.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-005802 |
| 2024-01-10 | 07:37 ET | [8-K](/filings/0001437749-24-001061.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-001061 |
| 2023-11-06 | 17:01 ET | [10-Q](/filings/0001437749-23-030412.md) | Quarterly report, period 2023-09-30 | 0001437749-23-030412 |
| 2023-11-01 | 07:33 ET | [8-K](/filings/0001437749-23-029660.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-029660 |
| 2023-08-04 | 16:30 ET | [10-Q](/filings/0001558370-23-013429.md) | Quarterly report, period 2023-06-30 | 0001558370-23-013429 |
| 2023-08-01 | 07:29 ET | [8-K](/filings/0001558370-23-012631.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-012631 |
| 2023-06-15 | 16:30 ET | [8-K](/filings/0001558370-23-011140.md) | 5.07 Shareholder vote results | 0001558370-23-011140 |
| 2023-05-08 | 07:59 ET | [10-Q](/filings/0001558370-23-008385.md) | Quarterly report, period 2023-03-31 | 0001558370-23-008385 |
| 2023-05-01 | 16:17 ET | [DEF 14A](/filings/0001558370-23-007490.md) | Proxy statement | 0001558370-23-007490 |
| 2023-05-01 | 07:35 ET | [8-K](/filings/0001558370-23-007393.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-007393 |
| 2023-03-01 | 17:21 ET | [10-K](/filings/0001558370-23-002610.md) | Annual report, period 2022-12-31 | 0001558370-23-002610 |
| 2023-02-28 | 07:33 ET | [8-K](/filings/0001558370-23-002239.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-002239 |
| 2022-12-28 | 16:30 ET | [8-K](/filings/0001558370-22-019019.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-22-019019 |
| 2022-11-10 | 07:38 ET | [8-K](/filings/0001558370-22-017292.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-22-017292 |
| 2022-11-09 | 16:30 ET | [10-Q](/filings/0001558370-22-017180.md) | Quarterly report, period 2022-09-30 | 0001558370-22-017180 |
| 2022-08-09 | 16:01 ET | [10-Q](/filings/0001558370-22-012854.md) | Quarterly report, period 2022-06-30 | 0001558370-22-012854 |
| 2022-08-08 | 07:37 ET | [8-K](/filings/0001558370-22-012517.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-22-012517 |

Page 1 of 7. [Older](/companies/tgtx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:01 ET. No prices; not investment advice.